Rafferty Asset Management’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-307,369
| Closed | -$9.11M | – | 1104 |
|
|
2023
Q4 | $9.11M | Sell |
307,369
-259,616
| -46% | -$7.7M | 0.04% | 305 |
|
|
2023
Q3 | $9M | Buy |
566,985
+229,699
| +68% | +$3.65M | 0.05% | 249 |
|
|
2023
Q2 | $6.36M | Sell |
337,286
-1,030,684
| -75% | -$19.4M | 0.04% | 358 |
|
|
2023
Q1 | $5.25M | Sell |
1,367,970
-243
| -0% | -$933 | 0.04% | 373 |
|
|
2022
Q4 | $6.79M | Buy |
1,368,213
+420,762
| +44% | +$2.09M | 0.06% | 308 |
|
|
2022
Q3 | $4.53M | Buy |
947,451
+199,435
| +27% | +$953K | 0.05% | 352 |
|
|
2022
Q2 | $3.37M | Sell |
748,016
-104,868
| -12% | -$472K | 0.03% | 367 |
|
|
2022
Q1 | $4.06M | Buy |
852,884
+439,850
| +106% | +$2.09M | 0.02% | 427 |
|
|
2021
Q4 | $3.07M | Buy |
413,034
+109,741
| +36% | +$814K | 0.02% | 533 |
|
|
2021
Q3 | $1.72M | Sell |
303,293
-99,253
| -25% | -$563K | 0.01% | 678 |
|
|
2021
Q2 | $2.65M | Buy |
402,546
+24,784
| +7% | +$163K | 0.02% | 555 |
|
|
2021
Q1 | $3.06M | Buy |
377,762
+298,247
| +375% | +$2.42M | 0.02% | 481 |
|
|
2020
Q4 | $513K | Sell |
79,515
-149,605
| -65% | -$965K | 0.01% | 682 |
|
|
2020
Q3 | $825K | Buy |
229,120
+127,933
| +126% | +$461K | 0.01% | 605 |
|
|
2020
Q2 | $465K | Buy |
101,187
+86,546
| +591% | +$398K | 0.01% | 732 |
|
|
2020
Q1 | $50K | Sell |
14,641
-109,672
| -88% | -$375K | ﹤0.01% | 574 |
|
|
2019
Q4 | $635K | Sell |
124,313
-195,676
| -61% | -$1,000K | 0.01% | 651 |
|
|
2019
Q3 | $774K | Buy |
+319,989
| New | +$774K | 0.01% | 593 |
|
|
2019
Q2 | – | Sell |
-722,765
| Closed | -$1.96M | – | 863 |
|
|
2019
Q1 | $1.96M | Buy |
+722,765
| New | +$1.96M | 0.03% | 403 |
|